FAP-2286 is a peptide-based compound designed as a pharmaceutical raw material for targeted radiotherapeutic applications. It is primarily used in research and manufacturing settings for the development of radiopharmaceuticals.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing FAP-2286??
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Fospropofol
active pharmaceutical ingredient
Prajmalium bitartrate
pharmaceutical raw material
IDRX-42
pharmaceutical raw material
Cefazolin
pharmaceutical raw material
(5R,11S,17S,20S,23S,26S,29R)-23-(3-amino-3-oxopropyl)-26-benzyl-5-(hexanoylamino)-20-[(1R)-1-hydroxyethyl]-6,12,18,21,24,27-hexaoxo-35-[2-[[2-[4,7,10-tris(carboxymethyl)-1,4,7,10-tetrazacyclododec-1-yl]acetyl]amino]ethylsulfanylmethyl]-3,31-dithia-7,13,19,22,25,28-hexazatetracyclo[31.3.1.07,11.013,17]heptatriaconta-1(37),33,35-triene-29-carboxylic acid
UHKLVUPDBJFFBB-ZCDGVBLYSA-N
CCCCCC(=O)N[C@H]1CSCC2=CC(=CC(=C2)CSCCNC(=O)CN3CCN(CCN(CCN(CC3)CC(=O)O)CC(=O)O)CC(=O)O)CSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]4CCCN4C(=O)[C@@H]5CCCN5C1=O)[C@@H](C)O)CCC(=O)N)CC6=CC=CC=C6)C(=O)O
Sourcing FAP-2286??
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.